Publications by authors named "David Reasner"

Claim this Profile
R
Remote-Use Applications of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised Clinical Outcome Assessment Tool: A Scoping Review.
Nivedita L Bhushan, Carla DeMuro Romano, Julie Gras-Najjar, Jenna Reno, Nicholas Rockwood, David Reasner

Value Health· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updated Recommendations on Evidence Needed to Support Measurement Comparability Among Modes of Data Collection for Patient-Reported Outcome Measures: A Good Practices Report of an ISPOR Task Force.
Paul O'Donohoe, David S Reasner, Sarrit M Kovacs, Bill Byrom, Sonya Eremenco

Value Health· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Should responder analyses be conducted on continuous outcomes?
Robert Abugov, Jennifer Clark, Laura Higginbotham, Feng Li, Lei Nie, David Reasner

Pharm Stat· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparability of a provisioned device versus bring your own device for completion of patient-reported outcome measures by participants with chronic obstructive pulmonary disease: quantitative study findings.
Stacie Hudgens, Louise Newton, Sonya Eremenco, Mabel Crescioni, Tara Symonds, David S Reasner

J Patient Rep Outcomes· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparability of a provisioned device versus bring your own device for completion of patient-reported outcome measures by participants with chronic obstructive pulmonary disease: qualitative interview findings.
Louise Newton, Oliver Knight-West, Sonya Eremenco, Stacie Hudgens, Mabel Crescioni, David S Reasner

J Patient Rep Outcomes· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Best Practice Recommendations: User Acceptance Testing for Systems Designed to Collect Clinical Outcome Assessment Data Electronically.
Sarah Gordon, Jennifer Crager, Cindy Howry, Alexandra I Barsdorf, Jeff Cohen, David S Reasner

Ther Innov Regul Sci· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intestinal Guanylate Cyclase-C mRNA Expression in Duodenum and Colon of Children.
Mitchell B Cohen, Benjamin D Gold, Stavra A Xanthakos, Nicholas CaJacob, Taryn Weissman, David S Reasner

J Pediatr Gastroenterol Nutr· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Trial of 2 Delayed-Release Formulations of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation.
William D Chey, Gregory S Sayuk, Wilmin Bartolini, David S Reasner, Susan M Fox

Am J Gastroenterol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation of an iPSC line (AKOSi004-A) from fibroblasts of a female adult NPC1 patient, carrying the compound heterozygous mutation p.Val1023Serfs*15/p.Gly992Arg and of an iPSC line (AKOSi005-A) from a female adult control individual.
Christin Völkner, Maik Liedtke, Janine Petters, Jan Lukas, Hugo Murua Escobar, David Reasner

Stem Cell Res· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive assessment of patients with irritable bowel syndrome with constipation and chronic idiopathic constipation using deterministically linked administrative claims and patient-reported data: the Chronic Constipation and IBS-C Treatment and Outcomes Real-World Research Platform (CONTOR).
Douglas C A Taylor, Jessica L Abel, Carolyn Martin, Jalpa A Doshi, Breanna Essoi, David S Reasner

J Med Econ· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Stool Consistency on Bowel Movement Satisfaction in Patients With IBS-C or CIC Treated With Linaclotide or Other Medications: Real-World Evidence From the CONTOR Study.
Douglas C A Taylor, Jessica L Abel, Jalpa A Doshi, Carolyn Martin, Alyssa Goolsby Hunter, David S Reasner

J Clin Gastroenterol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IW-3718 Reduces Heartburn Severity in Patients With Refractory Gastroesophageal Reflux Disease in a Randomized Trial.
Michael F Vaezi, Ronnie Fass, Nimish Vakil, David S Reasner, Robert S Mittleman

Gastroenterology· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of linaclotide for opioid-induced constipation in patients with chronic noncancer pain syndromes from a phase 2 randomized study.
Darren M Brenner, Charles E Argoff, Susan M Fox, Wieslaw Bochenek, Patricia D'Astoli, David S Reasner

Pain· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale and design for a multicenter, randomized, double-blind, placebo-controlled, phase 2 study evaluating the safety and efficacy of the soluble guanylate cyclase stimulator praliciguat over 12 weeks in patients with heart failure with preserved ejection fraction (CAPACITY HFpEF).
James E Udelson, Gregory D Lewis, Sanjiv J Shah, Michael R Zile, Margaret M Redfield, David Reasner

Am Heart J· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychometric Analysis of the Abdominal Score From the Diary for Irritable Bowel Syndrome Symptoms-Constipation Using Phase IIb Clinical Trial Data.
Cheryl D Coon, Jennifer Hanlon, Jessica L Abel, J Jason Lundy, Robyn T Carson, David S Reasner

Value Health· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation and Validation of the Modified Reflux Symptom Questionnaire-Electronic Diary in Patients With Persistent Gastroesophageal Reflux Disease.
David A Andrae, Jennifer Hanlon, Mary Lynn Cala, Kayla Scippa, Christina Graham, David Reasner

Clin Transl Gastroenterol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response scale selection in adult pain measures: results from a literature review.
Shima Safikhani, Katharine S Gries, Jeremiah J Trudeau, David Reasner, Katja Rüdell

J Patient Rep Outcomes· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Linaclotide in irritable bowel syndrome with constipation: A Phase 3 randomized trial in China and other regions.
Yunsheng Yang, Jingyuan Fang, Xiaozhong Guo, Ning Dai, Xizhong Shen, David S Reasner

J Gastroenterol Hepatol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a Symptom-Focused Patient-Reported Outcome Measure for Functional Dyspepsia: The Functional Dyspepsia Symptom Diary (FDSD).
Fiona Taylor, Sophie Higgins, Robyn T Carson, Sonya Eremenco, Catherine Foley, David S Reasner

Am J Gastroenterol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-Dose Linaclotide (72 μg) for Chronic Idiopathic Constipation: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial.
Philip Schoenfeld, Brian E Lacy, William D Chey, Anthony J Lembo, Caroline B Kurtz, David S Reasner

Am J Gastroenterol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the Diabetic Gastroparesis Patient Experience: Patient Exit Interviews.
Claire M Ervin, David S Reasner, Jennifer T Hanlon, Sheri E Fehnel

Adv Ther· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a Symptom-Based Patient-Reported Outcome Instrument for Functional Dyspepsia: A Preliminary Conceptual Model and an Evaluation of the Adequacy of Existing Instruments.
Fiona Taylor, David S Reasner, Robyn T Carson, Linda S Deal, Catherine Foley

Patient· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Site-Based Versus Central Ratings in a Study of Generalized Anxiety Disorder.
Janet B W Williams, Kenneth A Kobak, Earl Giller, David S Reasner, Lisa Curry

J Clin Psychopharmacol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Catechol-O-methyltransferase genotype as modifier of superior responses to venlafaxine treatment in major depressive disorder.
Seth C Hopkins, David S Reasner, Kenneth S Koblan

Psychiatry Res· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis